Expertise in
3
conditions

Mats Johnson

Goeteborg, O, SE 
Expertise in
3
conditions
Goeteborg, O, SE 

Overview

Mats Johnson practices practicing medicine in Goeteborg, Sweden.

Mr. Johnson is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Attention Deficit Hyperactivity Disorder (ADHD), Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus Infections, Obsessive-Compulsive Disorder (OCD), and Autism Spectrum Disorder.

He is actively involved in clinical research, co-authoring 48 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Goeteborg, O, Sweden
Other Locations
Mariestad, O, Sweden

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 4, Multicenter, 2-part Study Composed of a Randomized, Double-blind, Parallel-group, Placebo-controlled, Active-comparator, Dose-optimization Evaluation Followed by a 1-Year Open-label Evaluation to Assess the Safety and Efficacy of Guanfacine Hydrochloride Prolonged-release (SPD503) in Children and Adolescents Aged 6 to 17 Years With Attention-deficit/Hyperactivity Disorder
A Phase 4, Multicenter, 2-part Study Composed of a Randomized, Double-blind, Parallel-group, Placebo-controlled, Active-comparator, Dose-optimization Evaluation Followed by a 1-Year Open-label Evaluation to Assess the Safety and Efficacy of Guanfacine Hydrochloride Prolonged-release (SPD503) in Children and Adolescents Aged 6 to 17 Years With Attention-deficit/Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: April 13, 2026
Intervention Type: Drug, Other
Study Drugs: Guanfacine hydrochloride (TAK-503), Atomoxetine hydrochloride
Study Phase: Phase 4

48 Total Publications

Trade-off between speed and accuracy: associations between obsessive-compulsive symptoms and meticulousness in PANS.
Trade-off between speed and accuracy: associations between obsessive-compulsive symptoms and meticulousness in PANS.
Journal: Journal of clinical and experimental neuropsychology
Published: January 21, 2026

Frequently Asked Questions about Mats Johnson

Is Mats Johnson a top-rated expert for Attention Deficit Hyperactivity Disorder (ADHD)?

MediFind is an objective health platform that identifies experts based on real-world data. Mats Johnson is classified as an Advanced expert for Attention Deficit Hyperactivity Disorder (ADHD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Mats Johnson participate in research or clinical trials?

Yes. Mats Johnson has published 48 articles and abstracts on conditions like Attention Deficit Hyperactivity Disorder (ADHD). You can view a list of Mats Johnson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Johnson's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile